# India Atherectomy Devices Market > India Atherectomy Devices Market Research Report: Size, Share, Trend Analysis By Types (Directional Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices), By Applications (Coronary Artery Disease, Peripheral Artery Disease, Carotid Artery Disease), By End-user (Hospitals, Cardiac Catheterization Labs, Ambulatory Surgical Centers), and By Material (Stainless Steel, Polymers, Composites) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.16% - **2024:** $ 69.85 Million - **2025:** $ 73.45 Million - **2035:** $ 121.45 Million - **Key Players:** Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) **Report ID:** MRFR/HC/52054-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/india-atherectomy-devices-market-53816 --- ## Market Summary ## **India Atherectomy Devices Market Overview** As per MRFR analysis, the India Atherectomy Devices Market Size was estimated at 83.5 (USD Million) in 2023.The India Atherectomy Devices Market is expected to grow from 87.48(USD Million) in 2024 to 150 (USD Million) by 2035. The India Atherectomy Devices Market CAGR (growth rate) is expected to be around 5.024% during the forecast period (2025 - 2035). **Key India Atherectomy Devices Market Trends Highlighted** The market for atherectomy devices in India is showing several noteworthy developments that are indicative of the changing cardiovascular care industry. The rising incidence of cardiovascular illnesses, which is fueled by dietary choices that contribute to ailments like diabetes and hypertension as well as changes in lifestyle and urbanization, is one of the major market drivers. There are plenty of chances to increase demand for sophisticated atherectomy devices as the population ages and health consciousness increases. Improvements in this field are also being fueled by government programs that assist healthcare infrastructure and the implementation of advantageous laws. Minimally invasive procedures are becoming more and more popular in India, according to recent trends. These methods are preferred by both patients and healthcare workers since they usually lead to faster healing periods and fewer hospital stays. Treatment paradigms are also changing as a result of the emergence of technologically sophisticated technologies like rotational atherectomy systems and lasers. Additionally, there is an increasing focus on educating and training qualified medical personnel to use these cutting-edge tools efficiently, improving patient outcomes. Expanding the use of atherectomy devices in different healthcare environments, such as rural places where access to cutting-edge cardiac care is still difficult, presents opportunities. Partnerships between healthcare practitioners and medical device makers can increase device knowledge and availability, enabling more patients to get cutting-edge therapies. The market may see significant increase as a result of India's continued emphasis on clinical research and trials, which may encourage the use of atherectomy devices. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **India Atherectomy Devices Market Drivers** **Increasing Prevalence of Cardiovascular Diseases** The rise in the incidence of cardiovascular diseases in India is a significant driver for the India [Atherectomy Devices Market](../../../reports/atherectomy-devices-market-7322). According to the Indian Heart Association, cardiovascular diseases are responsible for about 27% of deaths in India, translating to approximately 1.6 million deaths annually. This alarming statistic is primarily due to lifestyle changes, such as increased tobacco usage, unhealthy dietary habits, and sedentary lifestyles. The Government of India has launched various initiatives like the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS), which aim to reduce the burden of these diseases. These initiatives and the alarming rates of cardiovascular diseases present a substantial market potential for atherectomy devices, as these devices are vital in treating conditions such as atherosclerosis, which is prevalent in patients with cardiovascular issues. **Advancements in Medical Technology** Technological advancements in medical devices, particularly in atherectomy techniques, play a crucial role in fostering growth in the India Atherectomy Devices Market. Companies like Boston Scientific and Medtronic are investing heavily in Research and Development (R&D) to innovate and improve atherectomy devices. For instance, the recent introduction of advanced directional atherectomy devices that offer precision targeting of artery blockages has shown promising results. As per the Ministry of Electronics and Information Technology, the Government of India emphasizes digital health transformation, supporting the adoption of innovative healthcare technologies. The adoption of these cutting-edge devices is anticipated to lead to a higher success rate in cardiovascular interventions, paving the way for increased sales in the atherectomy device market. **Government Initiatives and Healthcare Policies** The Government of India has been proactive in enhancing healthcare access and affordability, which indirectly supports the growth of the India Atherectomy Devices Market. Initiatives like Ayushman Bharat aim to provide affordable healthcare to the underprivileged population, increasing the demand for advanced medical devices, including atherectomy tools. According to the National Health Authority, Ayushman Bharat aims to cover over 500 million individuals, significantly expanding the patient pool requiring cardiovascular treatments. Furthermore, the supportive healthcare policies promote better procurement processes for advanced medical devices within hospitals. As more healthcare facilities adopt these policies, the reliance on effective devices such as atherectomy products will likely surge. **India Atherectomy Devices Market Segment Insights** **Atherectomy Devices Market Type Insights** The India Atherectomy Devices Market is categorized into various types that significantly influence its overall structure and dynamics. Among these, Directional Atherectomy Devices have emerged as essential tools for minimally invasive procedures, providing physicians with the ability to precisely remove plaque from arteries. This segmentation allows for improved patient outcomes, reducing recovery times and hospitalization durations. Orbital Atherectomy Devices use a unique mechanism to reshape or remove plaque, which is particularly effective in treating heavily calcified lesions that are often challenging with conventional methods. Their ability to treat complex arterial blockages makes them a preferred choice among healthcare providers. Laser Atherectomy Devices are also gaining traction due to their effectiveness in precise tissue ablation, offering significant advantages in terms of reduced trauma and quick recovery for patients. The advanced technology used in these devices not only allows for greater efficacy but also enhances safety during surgical procedures. Rotational Atherectomy Devices are notable for their high-speed rotation capability that efficiently removes atherosclerotic material, making them a critical option for interventional cardiologists dealing with varied lesion types. The competitive landscape within the India Atherectomy Devices Market indicates a growing demand for these innovative solutions as they align with the healthcare trends towards less invasive and more effective treatments. As India's healthcare infrastructure continues to expand and improve, the focus on safe and efficient cardiac procedures places these devices in a position of significance, driving market growth and adoption in hospitals and specialized clinics across the country. The ongoing developments in this market reflect a commitment to enhancing the quality of care for patients with cardiovascular diseases, contributing to overall healthcare advancements in India. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Atherectomy Devices Market Application Insights** The Application segment of the India Atherectomy Devices Market is witnessing notable growth due to increasing incidences of cardiovascular diseases in the country. Coronary Artery Disease, being a leading cause of morbidity and mortality, plays a pivotal role in driving demand for atherectomy devices. Peripheral Artery Disease also significantly contributes to the increase in procedures, as it affects a large portion of the aging population and those with risk factors such as diabetes and hypertension prevalent in India. Furthermore, Carotid Artery Disease presents unique challenges and remains critical for preventing strokes. The rising awareness around these health issues have led to a heightened focus on innovative medical technologies, contributing to the overall market growth. In addition, government initiatives aimed at improving healthcare infrastructure and access for patients further underscore the trends of enhanced diagnostics and therapeutics within these areas. As a result, the market benefits from a supportive environment that encourages advancements in atherectomy devices tailored to treat these conditions effectively. All these factors combined establish a robust foundation for the India Atherectomy Devices Market, making the Applications segment significantly important in driving current and future developments. **Atherectomy Devices Market****End-use****r Insights** The End-user segment of the India Atherectomy Devices Market plays a crucial role in the growth and accessibility of treatment solutions in cardiovascular care. Within this segment, Hospitals represent a significant portion as they provide comprehensive services and advanced technology necessary for effective patient management. Cardiac Catheterization Labs are essential for performing minimally invasive procedures, offering specialized infrastructure that supports the adoption of atherectomy devices, thereby improving patient outcomes. Ambulatory Surgical Centers are gaining traction due to the shift towards outpatient care, enabling quicker recovery times and reducing healthcare costs for patients. The rise in cardiovascular diseases and the aging population in India further drive the demand for these end-user facilities. With government initiatives encouraging technological advancement and increased healthcare spending, there are ample opportunities for market growth in these establishments. The India Atherectomy Devices Market segmentation reflects these trends, highlighting the vital role each end-user plays in shaping the industry landscape and promoting better cardiovascular health among the population. **Atherectomy Devices Market Material Insights** The India Atherectomy Devices Market has been significantly shaped by its Material segment, which predominantly includes Stainless Steel, Polymers, and Composites. Stainless Steel is known for its strength and corrosion resistance, making it a popular choice in the manufacturing of atherectomy devices, as it ensures durability and reliability during procedures. Polymers, on the other hand, are gaining traction due to their lightweight nature and flexibility, contributing to patient comfort and ease of device handling. Composites, representing a blend of different materials, offer enhanced performance characteristics, catering to specific clinical requirements. The trends in this market reflect a shift towards materials that not only ensure effectiveness but also prioritize patient safety and ease of use for healthcare professionals. With the increasing prevalence of cardiovascular diseases in India, the demand for advanced atherectomy devices remains on the rise, driving the focus on innovative materials that can improve procedural outcomes. As such, the Material segment plays a critical role in the overall growth and advancement of the India Atherectomy Devices Market. **India Atherectomy Devices Market Key Players and Competitive Insights** The India Atherectomy Devices Market has emerged as a critical sector within the healthcare industry, largely driven by the increasing prevalence of cardiovascular diseases and the growing demand for advanced minimally invasive procedures. The competitive landscape is characterized by several key players who are actively engaged in technological innovations and strategic partnerships to gain market share. These companies are not only focusing on product development but are also increasingly investing in research and development to enhance the efficacy and safety of atherectomy devices. Additionally, regulatory compliance and market entry strategies, especially related to the complexities of the Indian medical device regulations, play a pivotal role in shaping the dynamics of competition within this sector. As the market evolves, companies with robust distribution networks and extensive clinical expertise are poised to emerge as leaders. Spectranetics has established a significant presence in the Indian Atherectomy Devices Market by focusing on the development of innovative technologies aimed at improving patient outcomes. The company has successfully positioned itself with a strong product portfolio that includes various atherectomy systems tailored for treating peripheral artery diseases and coronary artery disease. With a commitment to addressing the specific needs of the Indian healthcare ecosystem, Spectranetics has leveraged its cutting-edge technologies to establish a competitive edge. Its strengths lie in its well-trained sales force, extensive clinical data supporting its devices, and strategic collaborations with healthcare professionals. These factors have allowed Spectranetics to resonate well within the Indian market while enhancing healthcare providers’ trust in its offerings. Abbott Laboratories has made substantial inroads into the India Atherectomy Devices Market, supported by its comprehensive range of cardiovascular products that incorporate atherectomy solutions. The company has built a strong reputation for its advanced technologies that are designed to improve patient outcomes and expand treatment options for cardiac conditions. Key products in its portfolio include innovative devices that employ unique mechanisms for the safe and effective removal of arterial plaque. Abbott's strength lies in its established market presence, innovative research initiatives, and collaborations with local healthcare institutions. The company has engaged in strategic mergers and acquisitions to bolster its capabilities in the region, thereby enhancing its competitive landscape. By streamlining its operations and focusing on localized manufacturing, Abbott has managed to cater effectively to the nuances of the Indian healthcare market, which further solidifies its position as a prominent player in the atherectomy devices arena. **Key Companies in the India Atherectomy Devices Market Include:** - Spectranetics - Abbott Laboratories - Boston Scientific - Terumo - B. Braun - AngioDynamics - Medtronic - Cordis - Philips - iVascular - Hercules Medical - Avinger - Biotronik - Cardinal Health **India Atherectomy Devices****Market****Developments** In the India Atherectomy Devices Market, recent developments indicate a growing focus on technological advancements and regulatory approvals. In July 2023, Abbott Laboratories announced the launch of its new minimally invasive atherectomy system, aimed at enhancing treatment options for patients with peripheral artery disease. Boston Scientific also made strides in the market by expanding its portfolio of atherectomy devices, reflecting an increasing demand for innovative solutions in cardiovascular care. Notably, in September 2022, Medtronic received approval for its advanced atherectomy devices, further establishing its presence in India. The market has seen consolidation activities as well, with Cordis and Terumo engaging in strategic partnerships to enhance product offerings. In terms of mergers and acquisitions, no significant transactions have been recorded recently among the key players like Spectranetics, AngioDynamics, or B. Braun in India. The overall growth in the atherectomy devices market is being driven by an increased prevalence of cardiovascular diseases in the Indian population, alongside government initiatives aimed at improving healthcare infrastructure. As of recent reports, growth in market valuation within this sector is projected to continue, reflecting robust opportunities for both domestic and multinational companies. **India Atherectomy Devices Market Segmentation Insights** **Atherectomy Devices Market Type Outlook** - Directional Atherectomy Devices - Orbital Atherectomy Devices - Laser Atherectomy Devices - Rotational Atherectomy Devices **Atherectomy Devices Market Application Outlook** - Coronary Artery Disease - Peripheral Artery Disease - Carotid Artery Disease **Atherectomy Devices Market End-user Outlook** - Hospitals - Cardiac Catheterization Labs - Ambulatory Surgical Centers **Atherectomy Devices Market Material Outlook** - Stainless Steel - Polymers - Composites ## Market Drivers ### Rising Geriatric Population India's demographic shift towards an aging population is a significant factor influencing the atherectomy devices market. By 2025, it is projected that the elderly population will exceed 140 million, leading to an increased prevalence of age-related cardiovascular conditions. This demographic trend necessitates the development and availability of specialized medical devices tailored for older patients. The atherectomy devices market is likely to expand as healthcare providers adapt to the needs of this growing population segment. Furthermore, the increasing life expectancy in India suggests a higher demand for effective cardiovascular treatments, thereby driving the market for atherectomy devices. ### Advancements in Medical Technology Technological innovations in medical devices are transforming the landscape of the atherectomy devices market. The introduction of minimally invasive techniques and improved device designs enhances patient outcomes and reduces recovery times. For instance, the development of laser and rotational atherectomy devices has shown promising results in treating complex vascular lesions. As hospitals and clinics in India increasingly adopt these advanced technologies, the atherectomy devices market is expected to experience robust growth. The continuous evolution of medical technology, coupled with the need for effective cardiovascular treatments, positions the atherectomy devices market for significant advancements in the coming years. ### Growing Investment in Healthcare Sector The increasing investment in the healthcare sector in India is a vital driver for the atherectomy devices market. With both public and private sectors recognizing the importance of advanced medical technologies, funding for research and development is on the rise. This influx of capital facilitates the introduction of innovative atherectomy devices, catering to the evolving needs of healthcare providers. Moreover, the establishment of specialized cardiovascular centers across the country is likely to enhance the accessibility and availability of these devices. As a result, the atherectomy devices market is poised for growth, driven by the ongoing investment in healthcare infrastructure and technology. ### Increasing Prevalence of Lifestyle Diseases The rising incidence of lifestyle-related diseases in India, such as diabetes and hypertension, is a crucial driver for the atherectomy devices market. These conditions significantly elevate the risk of cardiovascular diseases, necessitating advanced treatment options. As per recent health reports, approximately 77 million individuals in India are affected by diabetes, which correlates with a higher demand for effective cardiovascular interventions. The growing awareness among healthcare professionals and patients regarding the importance of early diagnosis and treatment of cardiovascular issues further propels the market. Consequently, the atherectomy devices market is likely to witness substantial growth as healthcare providers seek innovative solutions to manage these lifestyle diseases. ### Government Initiatives for Healthcare Improvement The Indian government's commitment to enhancing healthcare infrastructure plays a pivotal role in the atherectomy devices market. Initiatives such as the National Health Mission aim to improve access to quality healthcare services across the country. With increased funding and support for medical technology, hospitals are more inclined to adopt advanced devices, including atherectomy tools. The government's focus on reducing the burden of cardiovascular diseases through public health campaigns and improved healthcare access is expected to drive the demand for atherectomy devices. As a result, the market is poised for growth, with an anticipated increase in device adoption in both urban and rural healthcare settings. ## Future Outlook The [Atherectomy Devices Market](https://www.marketresearchfuture.com/reports/atherectomy-devices-market-7322) is projected to grow at a 5.16% CAGR from 2025 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure. **New opportunities:** - Development of minimally invasive atherectomy systems for outpatient procedures. - Partnerships with hospitals for exclusive device supply agreements. - Investment in AI-driven analytics for personalized treatment plans. By 2035, the atherectomy devices market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: Directional Atherectomy Devices (Largest) vs. Laser Atherectomy Devices (Fastest-Growing) In the India atherectomy devices market, the market share distribution reveals that Directional Atherectomy Devices hold the largest share, showcasing their dominance in clinical practices. Following this, Orbital and Rotational Atherectomy Devices play a crucial role, but to a lesser extent, while Laser Atherectomy Devices are quickly gaining traction among healthcare providers. The growth trends in this segment are significantly influenced by advancements in technology and increasing prevalence of cardiovascular diseases. Rising awareness and improvements in healthcare infrastructure are driving the adoption of these devices. Furthermore, patient preference for minimally invasive procedures is propelling Laser Atherectomy Devices, marking them as the fastest-growing category in the market. Directional Atherectomy Devices (Dominant) vs. Laser Atherectomy Devices (Emerging) Directional Atherectomy Devices are characterized by their ability to precisely target and remove atherosclerotic plaque, making them a preferred choice among cardiologists. Their dominant position stems from established clinical efficacy and widespread acceptance. In contrast, Laser Atherectomy Devices are emerging with innovative technology to facilitate quick recovery and minimal damage to surrounding tissues, increasing their appeal. As hospitals aim to enhance patient outcomes, the demand for Laser Atherectomy Devices is rising. This competition within the sector reflects a dynamic market landscape, where both segments are pivotal for therapeutic advancements in cardiovascular treatments. ### By Application: Coronary Artery Disease (Largest) vs. Peripheral Artery Disease (Fastest-Growing) The distribution of market share within the application segment of the India atherectomy devices market is primarily dominated by the coronary artery disease category. This segment enjoys a substantial portion of market presence due to the high prevalence of coronary artery conditions among the population. In contrast, the peripheral artery disease segment is gaining traction, attributed to increasing awareness and advancements in treatment technologies that cater to patients suffering from peripheral artery conditions. The growth trends in this segment reveal a significant trajectory, primarily fueled by the rising incidence of cardiovascular diseases and enhanced healthcare accessibility. The emergence of innovative atherectomy devices has contributed to expanding treatment options for patients, particularly in the peripheral artery disease segment, which is now recognized as the fastest-growing area. These trends indicate a shift towards more targeted treatments, leading to improved patient outcomes and market growth. Coronary Artery Disease (Dominant) vs. Peripheral Artery Disease (Emerging) In the India atherectomy devices market, coronary artery disease is the dominant application segment, characterized by advanced treatment protocols and widespread adoption of atherectomy technologies. This segment benefits from robust clinical support and established guidelines that enhance both patient safety and procedural efficacy. Conversely, the peripheral artery disease segment is emerging rapidly, driven by a growing patient base and innovative device introductions that cater specifically to this condition. Enhanced awareness programs and the integration of atherectomy in standard treatment regimens are propelling this segment forward. Together, these segments illustrate the dynamic nature of the India atherectomy devices market, highlighting a strong demand for effective solutions in managing various artery-related diseases. ### By End User: Hospitals (Largest) vs. Cardiac Catheterization Labs (Fastest-Growing) In the India atherectomy devices market, hospitals are the largest end user segment, commanding a significant share due to their expansive operations and comprehensive patient care services. This segment benefits from the increasing prevalence of cardiovascular diseases, leading to higher procedural volumes which directly contributes to the overall demand for atherectomy devices. Conversely, cardiac catheterization labs, while currently smaller, are the fastest-growing segment, driven by advancements in minimally invasive procedures and technologies that enhance patient outcomes. The growth of cardiac catheterization labs can be attributed to the rising adoption of innovative atherectomy devices designed for specific patient needs and the overall shift towards outpatient procedures. Moreover, greater collaboration between hospitals and specialized labs is expected to bolster the performance of this segment, as more procedures are funneled through these facilities, leading to an enhanced market outlook for atherectomy devices in this area. Hospitals (Dominant) vs. Cardiac Catheterization Labs (Emerging) Hospitals represent the dominant segment in the India atherectomy devices market, characterized by their extensive infrastructure and ability to cater to a wide range of medical emergencies, including advanced cardiovascular treatments. They are equipped with the necessary technology and professionals to handle complex procedures. In contrast, cardiac catheterization labs are an emerging segment focusing on specialized cardiac interventions. These labs are becoming increasingly integrated within healthcare systems and are expanding their capabilities to meet the growing demand for less invasive surgical options, positioning them as critical players in the evolving landscape of cardiovascular care. ### By Material: Stainless Steel (Largest) vs. Polymers (Fastest-Growing) In the India atherectomy devices market, the material segment is primarily dominated by stainless steel, which holds the largest market share due to its durability and proven effectiveness in various medical applications. Polymers, on the other hand, are experiencing significant growth, driven by their lightweight properties and versatility, making them increasingly popular among manufacturers and healthcare providers. The growth trends within this segment reflect a shift towards innovation and improving patient outcomes. The rise in procedural volumes and an increasing preference for minimally invasive procedures are propelling the demand for advanced materials. Polymers are particularly favored for their flexibility and reduced thrombogenic properties, while stainless steel continues to be essential for its strength and reliability in atherectomy procedures. Material: Stainless Steel (Dominant) vs. Polymers (Emerging) Stainless steel is the dominant material in the atherectomy devices market, recognized for its mechanical strength, corrosion resistance, and biocompatibility. It is widely used in various medical instruments, ensuring reliability during procedures. The segment attracts significant investment due to continuous enhancements in manufacturing techniques. Conversely, polymers are emerging as a favorable alternative, especially in creating devices that require greater flexibility and adaptability to patient anatomy. Their lightweight nature reduces procedural complications, thus enhancing patient comfort. This transition towards polymers points to an innovative trend that highlights the industry's response to evolving technology and patient needs, establishing them as a critical focus in future product development. ## Competitive Benchmarking The atherectomy devices market in India is characterized by a dynamic competitive landscape, driven by increasing cardiovascular diseases and a growing aging population. Major players such as Boston Scientific (US), Medtronic (US), and Abbott Laboratories (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Boston Scientific (US) emphasizes technological advancements in its product offerings, while Medtronic (US) is known for its extensive research and development initiatives aimed at improving patient outcomes. Abbott Laboratories (US) has been actively pursuing collaborations with local healthcare providers to expand its reach, indicating a trend towards localized strategies that cater to specific market needs.The market structure appears moderately fragmented, with several key players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance efficiency and reduce costs. This approach not only strengthens their competitive positioning but also allows for quicker response times to market demands. The collective influence of these major players shapes a competitive environment where innovation and operational efficiency are paramount. In September Medtronic (US) announced the launch of its latest atherectomy device, which incorporates advanced imaging technology to enhance procedural accuracy. This strategic move is significant as it aligns with the growing demand for precision in cardiovascular interventions, potentially setting a new standard in the market. The introduction of such innovative products is likely to bolster Medtronic's competitive edge and attract a broader customer base. In October Abbott Laboratories (US) entered into a partnership with a leading Indian healthcare provider to facilitate the distribution of its atherectomy devices across the country. This collaboration is strategically important as it not only enhances Abbott's market penetration but also demonstrates a commitment to addressing local healthcare challenges. By leveraging the expertise of local partners, Abbott is poised to improve accessibility and patient outcomes in the region. In August Boston Scientific (US) expanded its manufacturing capabilities in India, aiming to increase production capacity for its atherectomy devices. This expansion reflects a strategic focus on meeting the rising demand in the Indian market while also reducing lead times. Such investments in local manufacturing are likely to enhance Boston Scientific's operational efficiency and strengthen its competitive position in the long term. As of November current trends in the atherectomy devices market indicate a shift towards digitalization and sustainability, with companies increasingly integrating AI technologies into their product development processes. Strategic alliances are becoming more prevalent, as firms recognize the value of collaboration in driving innovation. Looking ahead, competitive differentiation is expected to evolve, with a greater emphasis on technological advancements and supply chain reliability rather than solely on price. This shift suggests that companies that prioritize innovation and operational excellence will likely emerge as leaders in the evolving landscape. ## Recent News & Developments In the India Atherectomy Devices Market, recent developments indicate a growing focus on technological advancements and regulatory approvals. In July 2023, Abbott Laboratories announced the launch of its new minimally invasive atherectomy system, aimed at enhancing treatment options for patients with peripheral artery disease. Boston Scientific also made strides in the market by expanding its portfolio of atherectomy devices, reflecting an increasing demand for innovative solutions in cardiovascular care. Notably, in September 2022, Medtronic received approval for its advanced atherectomy devices, further establishing its presence in India. The market has seen consolidation activities as well, with Cordis and Terumo engaging in strategic partnerships to enhance product offerings. In terms of mergers and acquisitions, no significant transactions have been recorded recently among the key players like Spectranetics, AngioDynamics, or B. Braun in India. The overall growth in the atherectomy devices market is being driven by an increased prevalence of cardiovascular diseases in the Indian population, alongside government initiatives aimed at improving healthcare infrastructure. As of recent reports, growth in market valuation within this sector is projected to continue, reflecting robust opportunities for both domestic and multinational companies. ## Report Scope | MARKET SIZE 2024 | 69.85(USD Million) | | --- | --- | | MARKET SIZE 2025 | 73.45(USD Million) | | MARKET SIZE 2035 | 121.45(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.16% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Abbott Laboratories (US), Cardiovascular Systems (US), Spectranetics (US), B. Braun Melsungen AG (DE), Terumo Corporation (JP), Philips (NL) | | Segments Covered | Type, Application, End User, Material | | Key Market Opportunities | Advancements in minimally invasive techniques enhance growth potential in the atherectomy devices market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the atherectomy devices market in India. | | Countries Covered | India | ## Frequently Asked Questions **Q: What is the current valuation of the India atherectomy devices market?** A: The market valuation was $69.85 Million in 2024. **Q: What is the projected market size for the India atherectomy devices market by 2035?** A: The projected valuation for 2035 is $121.45 Million. **Q: What is the expected CAGR for the India atherectomy devices market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.16% during the forecast period. **Q: Which companies are the key players in the India atherectomy devices market?** A: Key players include Boston Scientific, Medtronic, Abbott Laboratories, and others. **Q: What are the main types of atherectomy devices available in the market?** A: The main types include Directional, Orbital, Laser, and Rotational atherectomy devices. **Q: What was the market size for Directional Atherectomy Devices in 2024?** A: The market size for Directional Atherectomy Devices was between $15.0 Million and $25.0 Million. **Q: How does the market for Laser Atherectomy Devices compare to other types?** A: The market size for Laser Atherectomy Devices ranged from $20.0 Million to $30.0 Million, indicating strong demand. **Q: What applications drive the demand for atherectomy devices in India?** A: The primary applications are Coronary Artery Disease, Peripheral Artery Disease, and Carotid Artery Disease. **Q: What is the expected market size for Peripheral Artery Disease applications by 2035?** A: The market size for Peripheral Artery Disease applications is projected to be between $30.0 Million and $50.0 Million. **Q: Which end users are the largest consumers of atherectomy devices?** A: The largest consumers are hospitals, cardiac catheterization labs, and ambulatory surgical centers. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-atherectomy-devices-market-53816*